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Carbon metabolic pathways are important to the pathogenesis of Mycobacterium tuberculosis,
the causative agent of tuberculosis. However, extremely little is known about metabolic regulation
in mycobacteria. There is growing evidence for lysine acetylation being a mechanism of regulating
bacterial metabolism. Lysine acetylation is a post-translational modification in which an acetyl
group is covalently attached to the side chain of a lysine residue. This modification is mediated by
acetyltransferases, which add acetyl groups, and deacetylases, which remove the acetyl groups.
Here we set out to test whether lysine acetylation and deacetylation impact acetate metabolism in
the model mycobacteria Mycobacterium smegmatis, which possesses 25 candidate
acetyltransferases and 3 putative lysine deacetylases. Using mutants lacking predicted
acetyltransferases and deacetylases we showed that acetate metabolism in M. smegmatis is
regulated by reversible acetylation of acetyl-CoA synthetase (Ms-Acs) through the action of a
single pair of enzymes: the acetyltransferase Ms-PatA and the sirtuin deacetylase Ms-SrtN. We
also confirmed that the role of Ms-PatA in regulating Ms-Acs regulation depends on cAMP
binding. We additionally demonstrated a role for Ms-Acs, Ms-PatA and Ms-SrtN in regulating the
metabolism of propionate in M. smegmatis. Finally, along with Ms-Acs, we identified a candidate
propionyl-CoA synthetase, Ms5404, as acetylated in whole-cell lysates. This work lays the
foundation for studying the regulatory circuit of acetylation and deacetylation in the cellular context
of mycobacteria.
INTRODUCTION
Lysine acetylation is a reversible post-translational modi-
fication (PTM) where an acetyl group is added to the side
chain of a lysine residue. Much like phosphorylation,
acetylation is an efficient and dynamic way to both
positively and negatively regulate protein function. This
modification is extensively studied in eukaryotes, especially
with regard to its role in histone modifications. So far in
prokaryotes, there are only a few examples of proteins
regulated by lysine acetylation (Barak et al., 1992; Lima
et al., 2011, 2012; Ramakrishnan et al., 1998; Thao et al.,
2010; Yan et al., 2008), with the best-characterized
acetylated protein being acetyl-CoA synthetase (Acs)
(Barak et al., 2004; Starai et al., 2002). However, it is
likely that many more bacterial proteins are regulated by
lysine acetylation. Proteomic studies identified between
100 and 200 proteins with acetylated lysine residues in
Escherichia coli, Salmonella enterica, Erwinia amylovora and
Bacillus subtilis (Kim et al., 2013; Wang et al., 2010; Wu
et al., 2013; Yu et al., 2008; Zhang et al., 2009). These
proteins have functions in various processes; however,
metabolic enzymes are the largest class of acetylated
proteins identified in these studies.
Mycobacterium tuberculosis is the causative agent of
tuberculosis disease, which is responsible for 1.4 million
deaths per year (WHO, 2013). New drugs are needed to
control drug-resistant M. tuberculosis infections, and a
more complete understanding of M. tuberculosis biology
will guide such efforts. It is clear that the carbon metabolic
pathways of M. tuberculosis are critical to the growth and
persistence of this pathogen in the host (Marrero et al.,
Abbreviations: AUC, area under the curve; FDR, false discovery rate;
GNAT, Gcn5-related N-acetyltransferase; LC, liquid chromatography;
PTM, post-translational modification; RFU, relative fluorescence units;
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2010; McKinney et al., 2000; Muñoz-Elı́as & McKinney,
2005; Rhee et al., 2011). The ability of M. tuberculosis to adapt
its metabolism throughout infection is also believed to be
important (Eisenreich et al., 2010; Muñoz-Elı́as & McKinney,
2006; Rhee et al., 2011). However, extremely little is known
about metabolic regulation in any mycobacteria.
In this study, we investigated the biological consequence of
acetylation of Acs in the model mycobacterial species
Mycobacterium smegmatis. Acs converts the short chain
fatty acid acetate to acetyl-CoA, a central molecule in many
metabolic processes including the tricarboxylic acid cycle.
While there have been no prior studies of Dacs mutants of
mycobacteria, analysis of Dacs mutants of other bacteria
demonstrates a role for Acs in enabling growth when a low
concentration of acetate is present as the sole carbon source
(Castaño-Cerezo et al., 2011; Gardner & Escalante-
Semerena, 2009; Kumari et al., 1995; Starai et al., 2003).
The biological impact of reversible Acs acetylation has been
investigated in a small collection of bacteria, with the S.
enterica enzyme being one of the best-studied examples
(Barak et al., 2004; Castaño-Cerezo et al., 2011; Crosby
et al., 2010; Gardner et al., 2006). In S. enterica, Acs is
acetylated by protein acetyltransferase (Pat), a Gcn5-related
N-acetyltransferase (GNAT) (Starai & Escalante-Semerena,
2004). This acetylation inhibits Acs function (Fig. 1a)
(Starai & Escalante-Semerena, 2004). In S. enterica, the
deacetylase CobB removes the acetyl group, allowing Acs to
regain activity (Fig. 1a) (Starai et al., 2002). CobB is a
member of the NAD+-dependent sirtuin, or class III,
family of deacetylases. In B. subtilis, there are two
deacetylases involved in Acs regulation: a sirtuin SrtN
and a Zn-dependent class I deacetylase AcuC (Gardner &
Escalante-Semerena, 2009).
Lysine acetylation has been detected in mycobacteria by
anti-acetyl lysine Western blot (Nambi et al., 2010).
Furthermore, inspection of mycobacterial genomes reveals
genes encoding Acs and candidate lysine acetyltransferases
and deacetylases, including a large number of predicted
GNATs: 25 in M. smegmatis and 20 in M. tuberculosis
(UniProt Consortium, 2012). In vitro studies show that the
M. smegmatis Pat protein (Ms5458, Ms-PatA) and the M.
tuberculosis Pat (Rv0998, Mt-PatA), which share amino acid
homology with the S. enterica Pat, can acetylate purified M.
tuberculosis Acs (Rv3667, Mt-Acs) (Xu et al., 2011). Mt-PatA
has also been referred to as KATmt (Nambi et al., 2013). In
vitro studies further demonstrate that acetylated Mt-Acs can
be deacetylated by the M. tuberculosis Rv1151c protein or by
its M. smegmatis orthologue Ms5175 (Gu et al., 2009; Li et al.,
2011a; Xu et al., 2011). We refer to Rv1151c as Mt-SrtN
because it is the only predicted sirtuin deacetylase of M.
tuberculosis, and we call Ms5175 Ms-SrtN. There are,
however, multiple predicted deacetylases in M. smegmatis:
two predicted sirtuins, Ms5175 and Ms4620, and a putative
Zn-dependent class I deacetylase, Ms0171 (Fig. 1b).
In vitro studies argue that lysine acetylation regulates
mycobacterial Acs. However, in the context of the
mycobacterial cell the importance of lysine acetylation
and deacetylation to Acs and acetate metabolism has never
been demonstrated. Here, we carried out a phenotypic
analysis of M. smegmatis mutants lacking predicted
acetyltransferases and deacetylases, and showed that a
single pair of enzymes, Ms-PatA and Ms-SrtN, regulates
acetate metabolism, as well as propionate metabolism.
Mycobacterial Pat proteins are unusual in containing a
cAMP-binding domain, which is required for their
function in vitro (Lee et al., 2012; Nambi et al., 2010; Xu
et al., 2011). In our study, we confirmed that Ms-PatA
requires cAMP binding in cells. Finally, along with Acs, we
identified the predicted propionyl-CoA synthetase Ms5404
as being acetylated in M. smegmatis.
METHODS
Bacterial strains and growth conditions. For genetic manipula-
tions, M. smegmatis mc2155 was grown in 7H9 (Difco) with 0.5 %


















Fig. 1. Model of Acs function and regulation. (a) Acs performs the
first step of acetate metabolism by converting acetate to acetyl-
CoA. Acs can be lysine acetylated (AcsAc) by acetyltransferases,
which causes Acs to become inactive. The acetyl group can be
removed by deacetylases, allowing Acs to again convert acetate to
acetyl-CoA. (b) Phylogenetic tree of selected bacterial deacety-
lases. An unrooted phylogenetic tree was created using PATRIC
(Gillespie et al., 2011). The light grey box indicates the sirtuin
family of deacetylases, where numbers after each protein display
percent sequence similarity to S. enterica CobB. The mycobacter-
ial SrtN proteins group together and are the most closely related to
S. enterica CobB. Selected class I deacetylases are shown in the
dark grey box and the number after Ms0171 indicates percent
sequence similarity to B. subtilis AcuC. As expected, the class I
deacetylases form their own branch of the tree.
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37 uC. For growth curves, cultures were grown in M9 media (12.6 mM
Na2HPO4, 22 mM KH2PO4, 8 mM NaCl, 19 mM NH4Cl, 2 mM
MgSO4, 0.1 mM CaCl2) with 0.1 % tyloxapol. Provided carbon sources
included 0.5 % glucose and 0.2 % glycerol, 2.5 mM sodium acetate, or
2.5 mM sodium propionate. To enumerate c.f.u., cultures were diluted
and plated on 7H10 (Difco) with 0.5 % glucose, 0.2 % glycerol and
0.1 % tyloxapol. When needed, antibiotics were used at the following
concentrations: 20 mg ml21 kanamycin, 50 mg ml21 hygromycin.
DH5a E. coli was grown in LB broth (Fisher Scientific) with the
following antibiotics when necessary: 40 mg ml21 kanamycin, 150 mg
ml21 hygromycin, 100 mg ml21 ampicillin.
Mutant construction. M. smegmatis mutants were constructed via
recombineering (van Kessel & Hatfull, 2008; van Kessel et al., 2008).
Briefly, allelic exchange vectors were constructed by cloning 500–
800 bp upstream and downstream flanks of the target gene (see Table
S1, available in Microbiology Online, for primer information) on
either side of a hygromycin-resistance cassette in pMP614 (a kind gift
from Martin Pavelka, University of Rochester Medical Center,
Rochester, NY, USA). The resulting vector was linearized by digesting
with XbaI and KpnI, and was used to transform M. smegmatis mc2155
harbouring the multicopy Kan-marked plasmid pJV53, which encodes
the phage-derived recombinase genes needed for recombination of
linear DNA. Recombinase expression from pJV53 was induced by a 3 h
incubation with 0.2 % acetamide. Following induction, electrocompe-
tent cells were prepared and transformed with the linearized allelic
exchange vectors (Snapper et al., 1990). All mutants were confirmed by
Southern blot analysis (data not shown). Confirmed mutant strains
were cured of plasmid pJV53 by growing cultures to saturation without
antibiotic and screening for kanamycin-sensitive colonies. To engineer
multiple deletions in the same strain, the hygromycin-resistance gene
was removed via resolvase recognition sites using pMP854, which
expresses TnpR resolvase (a kind gift from Martin Pavelka). pMP854
was later cured from the deletion strains. A complete strain list is found
in Table 1 and plasmids are listed in Table 2.
Complementation vector construction. To complement muta-
tions, the gene of interest was amplified by PCR (see Table S1 for
primer information) and cloned into pCR2.1 by TA cloning
(Invitrogen). The resulting vectors were sequenced to verify the
genes were error-free, and then digested with MscI and HindIII (for
pJH33 and pJH40) or SmaI and HindIII (for pEP104), and cloned
into pMV261.kan, pJSC77 or pMV306.kan digested with the same
enzymes. To construct Ms-PatA R95K, the Stratagene QuikChange
site-directed mutagenesis protocol was used. Recovered plasmids
were sequenced to verify the R95K mutation. To C-terminally HA-tag
Ms-PatA and Ms-PatA R95K, PCR was performed with primers
containing the HA epitope-encoding sequence. The PCR products
were cloned into pCR2.1 by TA cloning and subcloned into
pMV306.kan.
Resazurin assays. M. smegmatis growth and viability were
monitored using resazurin. Cultures were grown in M9 media with
0.5 % glucose, 0.2 % glycerol, 0.1 % tyloxapol to saturation and then
subcultured into new media. At an OD600 of 1, cells were washed twice
in M9 0.1 % tyloxapol (no added carbon source) and diluted to
106 c.f.u. ml21. Cells (100 ml) were added to 96-well plates containing
media as indicated. After 24 h of growth at 37 uC, resazurin (12.5 mg
ml21 final concentration; Sigma) was added and fluorescence with
excitation at 530 nm and emission at 590 nm was monitored over
time. Values at 10 h post-resazurin addition are reported following
normalization to the fluorescence value of the wild-type strain in the
same growth media. A Student’s t-test was used to determine if datasets
were statistically significantly different. Negative controls always
included media with no cells and cells with no added carbon source.
Western blotting. Whole-cell lysates of M. smegmatis grown in
Mueller–Hinton media were prepared by 2–3 passages in a French
press. Unlysed cells were removed by centrifugation and protein
concentration was determined with a BCA assay (Pierce). Whole-cell
lysates were separated by SDS-PAGE. The acetylated lysine primary
antibody (Cell Signalling) was used at a 1 : 2500 dilution and was
incubated with either BSA or acetylated BSA (100 mg ml21 final
concentration) for 1 h on ice before addition to membranes. IRDye
800CW goat anti-rabbit polyclonal antibody (LI-COR) was used as
the secondary antibody at a 1 : 15 000 dilution. The HA antibody
(Covance) was used at a 1 : 20 000 dilution with the IRDye 680L T
goat anti-mouse secondary antibody (LI-COR) used at a 1 : 20 000
dilution. Western blot results were visualized with an Odyssey
fluorescence imaging system (LI-COR). Quantification of band
densitometry was performed using Image J software (W. S.
Rasband, NIH, Bethesda, MD, USA, 1997–2012; http://imagej.nih.
gov/ij/). As a control for protein loading, a polyclonal SigA antibody
(a kind gift from Murty Madiraju, The University of Texas Health
Science Center, Tyler, TX, USA) was used at 1 : 20 000.
In-gel trypsin digestion for MS analysis. For both the wild-type
and DdeAc mutant, 7 mg whole-cell lysate protein was separated on a
10 % SDS-PAGE gel (Bio-Rad). The protein bands were visualized by
Coomassie blue R-250 staining (Bio-Rad), and gel slices correspond-
ing to proteins 60–75 kDa in size were excised. Digestion of the
excised gel slices was performed using 20 mg sequencing grade trypsin
ml21 in 25 mM ammonium bicarbonate as described elsewhere
(Collins et al., 2008).
Liquid chromatography (LC)-MS-MS. Identification of proteins
was done using reversed-phase LC-MS-MS analysis on a 2D-nanoLC
Ultra system (Eksigent) coupled to an LTQ-Orbitrap Velos mass
spectrometer (Thermo Scientific). The Eksigent system was config-
ured to trap and elute peptides via a sandwiched injection of
~250 fmol sample. The trapping was performed on a 3 cm long,
Table 1. Bacterial strain list
Strain Description Source
mc2155 Wild-type M. smegmatis Snapper et al. (1990)
JDH032 mc2155 Dms-acs (ms6179) This study
JDH008 mc2155 Dms-srtN (ms5175) This study
JDH015 mc2155 Dms4620 This study
JDH037 mc2155 Dms0171 This study
JDH043 mc2155 Dms-srtN Dms4620 Dms0171 This study
JDH050 mc2155 Dms-patA This study
JDH051 mc2155 Dms-srtN Dms4620 Dms0171 Dms-patA This study
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100 mm i.d. C18 column, while elution was performed on a 15 cm long,
75 mm i.d., 5 m, 300 Å particle ProteoPep II integraFrit C18 column
(New Objective). Analytical separation of the tryptic peptides was
achieved with a 120 min linear gradient of 2–10 % buffer B at
200 nl min21, where buffer A was an aqueous solution of 0.1 % formic
acid and buffer B was a solution of 0.1 % formic acid in acetonitrile.
Mass spectrometric data acquisition was performed in a data-
dependent manner via high-energy collision dissociation of the top 10
most abundant ions a hybrid LTQ-Orbitrap. Velos mass spectrometer
mass spectra were processed, and peptide identification was
performed using the Andromeda search engine found in MaxQuant
software version 2.2.1 (Max Planck Institute, Germany). All protein
database searches were performed against the M. smegmatis protein
sequence database downloaded from PATRIC (Pathosystems
Resource Integration Center) (http://patricbrc.org; Virginia Bioinfor-
matics Institute, Blacksburg, VA, USA) (Gillespie et al., 2011).
It should be noted that the PATRIC annotation for Ms-Acs
(VBIMycSme59918_6019) differs from the National Center for
Biotechnology Information annotation (YP_890399.1) and was used
as a reference in this study because the molecular mass of Ms-Acs
observed on our Western blots corresponds with the PATRIC
annotation.
Peptides were identified using a target-decoy approach with a false
discovery rate (FDR) of 1 % (Bantscheff et al., 2012). A precursor ion
mass tolerance of 100 p.p.m. was used for the first search that allowed
for m/z retention time recalibration of precursor ions that were then
subjected to a main search using a precursor ion mass tolerance of
5 p.p.m. and a product ion mass tolerance 0.5 Da. Search parameters
included up to two missed cleavages at KR on the sequence (Cox &
Mann, 2011), and lysine acetylation and methionine oxidation as
dynamic PTMs. All acetylations representing a differential modifica-
tion of 42.037 Da on lysines were unambiguously localized to specific
residues using the built-in PTM score with a probability of .0.99.
Acetyl peptide and protein quantification. Label-free quantifica-
tion was based on peak area (Bondarenko et al., 2002; Chelius &
Bondarenko, 2002; Gunawardena et al., 2011). The measured area
under the curve (AUC) of m/z and retention time aligned extracted
ion chromatogram (XIC) of a peptide was performed via the label-
free quantification module found in MaxQuant (version 1.2.2.5).
Protein level quantification was performed using unique and razor
peptide features corresponding to identifications filtered with a
peptide FDR of 1 %, and protein FDR of 5 % and PTM FDR 1 %. Data
processing was performed using Peseus (version 1.2.0.17) (Max Planck
Institute, Germany) where relative quantification changes between
samples were reported as fold-change differences. MaxQuant acetylated
peptide-level quantification values were verified manually by integrat-
ing the AUC of the XIC using the Genesis peak detection and
integration algorithm found in Xcalibure software (Thermo Scientific).
RESULTS
Acs is required for acetate metabolism in
M. smegmatis
In other bacteria, Acs is required for growth on low levels
of acetate as a sole carbon source and acetylation negatively
regulates this activity (Castaño-Cerezo et al., 2011; Gardner
& Escalante-Semerena, 2009; Kumari et al., 1995; Starai
et al., 2003). Before investigating the impact of lysine
acetylation on Acs in mycobacteria, we first needed to
establish a role for Ms-Acs in enabling growth of M.
smegmatis on low levels of acetate. As there are no prior
reports of Dacs mutants of mycobacteria, we began by
constructing an M. smegmatis mutant with a deletion of the
annotated ms-acs gene (ms6179). Wild-type and the Dms-
acs mutant were grown in M9 minimal media containing
either glucose and glycerol or acetate for carbon sources. At
various time points, culture aliquots were serially diluted
and plated on glucose and glycerol containing agar to
determine the number of c.f.u. Although the c.f.u. ml21 of
the Dms-acs mutant was comparable to wild-type in
glucose and glycerol media over time, the mutant exhibited
a growth defect in media with acetate as the sole carbon
source (Fig. 2a, b). The acetate growth phenotype of the
Dms-acs mutant was complemented when the M. smegma-
tis ms-acs gene was expressed from a plasmid, which
confirmed that this phenotype is due to the loss of Ms-Acs.
As another way to test for an acetate metabolism defect we
employed a resazurin reduction assay (McNerney et al.,
Table 2. Plasmids used in this study
Plasmid Description Antibiotic marker Source
pMV261.kan Mycobacterial multicopy vector; hsp60-dependent promoter KanR Stover et al. (1991)
pMV306.kan Mycobacterial integrating vector KanR Stover et al. (1991)
pJSC77 HA-tag cloned into pMV261.kan KanR Glickman et al. (2000)
pJV53 Multicopy plasmid encoding phage Che9c 60 and 61 genes
under acetamide-inducible promoter
KanR van Kessel & Hatfull (2008);
van Kessel et al. (2008)
pMP614 res-Hyg-res plasmid for constructing allelic exchange vectors HygR Kind gift from Martin Pavelka
pMP854 tnpR expressing plasmid used to remove HygR marker from
mutant strains
KanR Kind gift from Martin Pavelka
pJH33 M. smegmatis ms-acs (ms6179) cloned into pMV261 KanR This study
pEP104 M. tuberculosis mt-srtN (rv1151c) cloned into pJSC77 KanR This study
pJH40 M. smegmatis ms-patA (ms5458) cloned into pMV306.kan KanR This study
pJH51 M. smegmatis ms-patA (ms5458) HA-tagged and cloned into
pMV306.kan
KanR This study
pJH52 M. smegmatis ms-patA R95K HA-tagged and cloned into
pMV306.kan
KanR This study
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Fig. 2. Ms-Acs is required for acetate metabolism in M. smegmatis. (a) Growth curve of wild-type (mc2155, pMV261), Dms-acs
(JDH032, pMV261) and Dms-acs complemented with ms-acs (JDH032, pJH33) strains in glucose/glycerol media. Aliquots
from liquid cultures were removed at the indicated time points and plated to enumerate c.f.u. ml”1. (b) Growth curve of wild-
type, Dms-acs and Dms-acs complemented with ms-acs strains in acetate media. Experiment is as described in (a). *P value of
,0.01 when comparing the wild-type and ms-acs strains. (c) Resazurin reduction in glucose/glycerol media. Liquid cultures of
wild-type, Dms-acs and Dms-acs complemented with ms-acs strains were grown in 96-well plates as described in Methods.
After 24 h, resazurin was added and relative fluorescence units (RFU) were measured over the next 20 h. (d) Resazurin
reduction in acetate media, as described for (c). (e) The 96-well plate 10 h after resazurin was added. Pink colour indicates
metabolically active cells, while blue shows low resazurin reduction and low metabolic activity. (f) Quantification of resazurin
fluorescence for cells grown in glucose/glycerol (white bars) and acetate (black bars). The fluorescence value at 10 h after
resazurin addition was normalized to that of the wild-type in each growth condition. *P value of ,0.01 when compared to wild-
type fluorescence in the same media. For (a–d) and (f), error bars denote the SD of three replicates.
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2000; Singh et al., 2006). Resazurin is a blue compound
that is reduced by metabolically active cells. When reduced,
resazurin is converted to a pink fluorescent product that
can be quantified to report on metabolic activity and cell
number. Strains were grown in a 96-well plate in either
glucose and glycerol or acetate-containing media. After
24 h incubation, resazurin was added and 10 h later
visually inspected. In glucose and glycerol media, the
wild-type, Dms-acs mutant and complemented ms-acs
strain all showed robust resazurin reduction, as indicated
by the pink colour (Fig. 2e). In acetate media, the wild-type
and complemented strain also reduced resazurin, although
the pink colour was not as strong as when the same strains
were grown with glucose and glycerol, which are known to
be better carbon sources. However, wells containing the
Dms-acs mutant in acetate media maintained a blue colour,
indicating reduced metabolic activity for the mutant (Fig.
2e). We also measured resazurin fluorescence over the
course of 20 h (Fig. 2c, d). All strains converted resazurin
at an equal rate in glucose and glycerol media. In acetate
media, the wild-type and complemented strain reduced
resazurin while the Dms-acs mutant showed very little to
no resazurin reduction. In fact, the resazurin reduction of
the Dms-acs mutant in acetate was comparable to what is
seen when M. smegmatis is incubated with no carbon
source (data not shown). For simplicity, we decided to
report these data at a single time point of 10 h post-
resazurin addition with the fluorescence value of each
strain set relative to that of wild-type in the same carbon
source (Fig. 2f). Taken together, the c.f.u. plating and
resazurin assays demonstrated that, like in other bacteria,
Ms-Acs is required for acetate metabolism and growth in
acetate media.
SrtN deacetylase regulates acetate metabolism in
M. smegmatis
Having established function for Ms-Acs, we tested whether
Ms-Acs and acetate metabolism are regulated by reversible
lysine acetylation (Fig. 1a). If Ms-Acs is inhibited by lysine
acetylation, there must exist at least one deacetylase that
removes the acetyl group to activate Ms-Acs. Inspection of
the M. smegmatis genome revealed three potential
deacetylases. Ms-SrtN (Ms5175) and Ms4620 have homo-
logy to the class III, or sirtuin, family of deacetylases. They
contain sirtuin consensus sequences and share amino acid
similarity with the bacterial sirtuins CobB of S. enterica and
SrtN of B. subtilis (Fig. 1b and Fig. S1). Ms-SrtN from M.
smegmatis is the orthologue of Mt-SrtN from M.
tuberculosis, with the two proteins sharing 81 % amino
acid similarity. Ms4620 has no obvious M. tuberculosis
orthologue. Ms0171 is a potential class I Zn-dependent
deacetylase that is similar to the class I deacetylase AcuC of
B. subtilis (Gardner & Escalante-Semerena, 2009) (Fig. 1b).
There is no evident M. tuberculosis orthologue of Ms0171.
To identify the deacetylase(s) that acts on acetylated Ms-
Acs in M. smegmatis, we deleted the genes encoding the
three deacetylases individually and in combination. We
predicted that in the absence of the responsible deacetylase,
Ms-Acs would become locked in an acetylated (inactive)
state resulting in an inability of M. smegmatis to utilize
acetate as the sole carbon source. A Dms-srtN mutant
behaved like wild-type M. smegmatis when grown in
glucose and glycerol media, as measured by resazurin
reduction (Fig. 3, white bars). However, in acetate media
the Dms-srtN mutant exhibited significantly reduced
metabolic activity, which is consistent with a function of
Ms-SrtN in deacetylating Ms-Acs (Fig. 3, black bars). The
acetate phenotype of the Dms-srtN mutant was comple-
mented by providing a copy of the M. tuberculosis srtN
(mt-srtN) gene. Together, these experiments demonstrated
that Ms-SrtN is required for M. smegmatis to optimally
metabolize acetate and further showed that Mt-SrtN of M.
tuberculosis can also carry out this function. The Dms-srtN
mutant phenotype was statistically significant compared to
wild-type; however, it is noteworthy that this phenotype
was not as severe as that of the Dms-acs mutant.
We also tested deletion mutants lacking ms4620 or ms0171.
Both of these mutants behaved like wild-type in glucose
and glycerol media as well as in acetate media, indicating
that on their own neither of these proteins is required for
Acs deacetylation (Fig. 3). It remained a possibility,
however, that the proteins have redundant deacetylase
functions. To address this possibility, we constructed an
unmarked mutant lacking all three M. smegmatis deacety-
lases, Dms-srtN Dms4620 Dms0171. We refer to this triple
deacetylase mutant as DdeAc. The DdeAc mutant exhibited
a phenotype similar to the single Dms-srtN mutant when
grown in acetate. Once again, introduction of the mt-srtN
gene was sufficient to restore acetate metabolism to the
DdeAc mutant. These results are consistent with negative
regulation of Ms-Acs by lysine acetylation and with the
function of Ms-SrtN and Mt-SrtN being to deacetylate
mycobacterial Acs and enable acetate metabolism.
PatA acetyltransferase regulates acetate
metabolism in M. smegmatis
The M. smegmatis PatA (Ms5458, Ms-PatA) has been
shown to acetylate Mt-Acs in vitro (Nambi et al., 2010; Xu
et al., 2011). However, the in vitro studies did not test any
of the 24 other putative GNATs in M. smegmatis that could
possibly act on Ms-Acs (UniProt Consortium, 2012). To
determine if Ms-PatA is the sole acetyltransferase that
regulates Ms-Acs in M. smegmatis, we constructed Dms-
patA M. smegmatis mutants in the wild-type and the DdeAc
mutant background. In the model where lysine acetylation
of Ms-Acs prevents the enzyme from converting acetate to
acetyl-CoA, we predicted that a Dms-patA mutation in a
wild-type strain would either enhance or have no effect on
acetate metabolism. However, if Ms-PatA is the only
acetyltransferase that acts on Ms-Acs then a ms-patA
mutation should rescue the acetate phenotype of the DdeAc
mutant. In other words, if Ms-Acs is not acetylated in the
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first place, then the absence of the Ms-SrtN deacetylase
should not impact acetate metabolism. Indeed, when the
Dms-patA deletion was introduced into the triple deacety-
lase mutant, creating the quadruple mutant DdeAc Dms-
patA, we found that it rescued the DdeAc acetate
phenotype (Fig. 4). The effect of the Dms-patA deletion
in the DdeAc mutant background could be complemented
when ms-patA was provided on a plasmid, resulting in the
return of an acetate metabolism defect. These results are
consistent with Ms-PatA being the only acetyltransferase
regulating Ms-Acs in M. smegmatis. The Dms-patA deletion
in a wild-type background had no effect on M. smegmatis
in glucose and glycerol media (Fig. 4). In acetate media the
Dms-patA mutant consistently had slightly higher meta-
bolic activity than wild-type, although this effect was not
statistically significant.
Interestingly, the Ms-PatA complementation experiments
revealed that Ms-PatA expression from a plasmid in the
DdeAc mutant caused a more severe acetate phenotype
than exhibited by the DdeAc mutant with Ms-PatA
expressed from its native chromosomal location (compare
the second and fourth black bars of Fig. 4). Although we
have not quantified Ms-PatA levels, this difference could
reflect higher expression off the complementing plasmid’s
hsp60 promoter than from the chromosomal ms-patA
locus.
Ms-PatA activity requires cAMP binding in
M. smegmatis
Mycobacterial Pat proteins are unique in that they contain
an N-terminal cAMP-binding domain, and Ms-PatA
requires cAMP for acetyltransferase activity in vitro
(Nambi et al., 2010; Xu et al., 2011). In order to test if
cAMP binding is also necessary for Ms-PatA activity in the
context of the M. smegmatis cell, we tested a Ms-PatA
protein in which the arginine at position 95, which is
required for cAMP binding in vitro, was substituted with a
lysine (Ms-PatA R95K) (Nambi et al., 2010). Unlike the
plasmid expressing Ms-PatA, when a plasmid expressing
Ms-PatA R95K was introduced into the DdeAc Dms-patA
strain, it failed to complement the Dms-patA mutation.
The difference between the level of acetate metabolism of
the DdeAc Dms-patA mutant expressing Ms-PatA com-
pared to the strain expressing Ms-PatA R95K was
statistically significant (Fig. 5a). To eliminate the possibility
that the R95K substitution in Ms-PatA compromised
protein stability, these experiments were performed with
HA-tagged Ms-PatA and Ms-PatA R95K, and Western
blotting confirmed equivalent levels of protein in the
strains (Fig. 5b). These experiments validate the import-
ance of cAMP binding to Ms-PatA, reported in vitro (Lee
et al., 2012; Nambi et al., 2010; Xu et al., 2011), to Ms-PatA
function in the cellular context of intact M. smegmatis.
Acetylated Ms-Acs is present in M. smegmatis
whole-cell lysates
To examine Ms-Acs acetylation in cells more directly we
used an antibody to acetylated lysine (Cell Signalling) and
performed Western blotting of whole-cell lysates of M.
smegmatis wild-type and the above-mentioned mutants
(Fig. 6a). In wild-type M. smegmatis, a band close to the
predicted molecular mass of Ms-Acs (69 kDa) was
recognized by the acetylated lysine antibody. This band
was absent in the Dms-acs mutant, but was present when




























Fig. 3. Ms-SrtN is required for acetate metabolism in M. smegmatis. Resazurin reduction was fluorescently monitored and
quantified as in Fig. 2(f). The strains included were wild-type (mc2155, pMV261), Dms-acs (JDH032, pMV261), Dms-srtN
(JDH008, pMV261), Dms-srtN complemented with mt-srtN (JDH008, pEP104), Dms4620 (JDH015, pMV261), Dms0171
(JDH037, pMV261), DdeAc (JDH043, pMV261), and DdeAc complemented with mt-srtN (JDH043, pEP104). White bars
indicate cultures with glucose/glycerol and black bars indicate cultures with acetate as the sole carbon source. *P ,0.01 when
compared to wild-type fluorescence in the same media. 3P ,0.01 when compared to Dms-acs fluorescence in the same
media.
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mutant, which confirmed the identity of this species as Ms-
Acs. To establish the specificity of the antibody for
acetylated lysines, we repeated the Western blotting in
the presence of acetylated BSA (Fig. 6b). Including
acetylated BSA led to a significant decrease in the intensity
of the Acs band, confirming that the antibody recognition
of Ms-Acs reflects its acetylation. Western blotting in the
presence of acetylated BSA also revealed an unidentified
protein that was non-specifically recognized by the
antibody (Fig. 6b, marked by the plus sign).
We next determined the effects of the deacetylase and ms-
patA mutations on Ms-Acs acetylation. Based on the
acetate phenotypes of the deacetylase mutants, which
prevented acetate metabolism presumably as a result of
trapping Ms-Acs in an acetylated state, we expected the
Dms-srtN and DdeAc mutants to show increased levels of
acetylated Ms-Acs. Indeed, in both the Dms-srtN and
DdeAc mutant strains, an increase in the amount of
acetylated Ms-Acs was observed compared to the wild-type



























Fig. 4. Ms-PatA regulates acetate metabolism in M. smegmatis. Resazurin reduction was fluorescently monitored and quantified
as in Fig. 2(f). The strains included were wild-type (mc2155, pMV261), DdeAc (JDH043, pMV261), DdeAc Dms-patA (JDH051,
pMV261), DdeAc Dms-patA complemented with ms-patA (JDH051, pJH40), Dms-patA (JDH050, pMV261), and Dms-patA
complemented with ms-patA (JDH050, pJH40). White bars indicate cultures with glucose/glycerol and black bars indicate
cultures with acetate as the sole carbon source. *P ,0.01 when compared to wild-type fluorescence in the same media.





















































Fig. 5. cAMP binding is required for Ms-PatA activity in M. smegmatis cells. (a) Resazurin reduction for cultures grown with
acetate as the sole carbon source was fluorescently monitored and quantified as in Fig. 2(f). The strains included were wild-type
(mc2155, pMV261), Dms-acs (JDH032, pMV261), DdeAc (JDH043, pMV261), DdeAc Dms-patA (JDH051, pMV261), DdeAc
Dms-patA complemented with ms-patA-HA (JDH051, pJH51), and DdeAc Dms-patA complemented with ms-patA R95K-HA
(JDH051, pJH52). *P,0.01 when compared to wild-type. 3P,0.01 when comparing DdeAc Dms-patA+ms-patA-HA and
DdeAc Dms-patA+ms-patA R95K-HA. (b) Western blot of whole-cell lysates of DdeAc Dms-patA complemented with ms-
patA-HA (JDH051, pJH51) and DdeAc Dms-patA complemented with ms-patA R95K-HA (JDH051, pJH52) probed with anti-
HA antibody. M, molecular mass marker.
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which mt-srtN was introduced on a plasmid into the
deacetylase mutant strains. Interestingly, in these mt-srtN
complemented strains the level of acetylated Ms-Acs only
decreased slightly, if at all (Fig. 6c). Because these mt-srtN
complemented strains were able to metabolize acetate like
wild-type (Fig. 3), this result suggested that the reduction
in Ms-Acs acetylation needed for acetate metabolism is
small.
Next we examined the levels of acetylated Ms-Acs in the
Dms-patA strain. If Ms-PatA is the sole acetyltransferase
that modifies Ms-Acs, there should be no acetylated
Ms-Acs in the Dms-patA background. In fact, Western
blotting revealed undetectable levels of acetylated Ms-Acs
when ms-patA was deleted (Fig. 6). In complementing
strains in which ms-patA was provided on an integrating
plasmid, acetylated Ms-Acs was again detected. These data
fit the model whereby, at least under the conditions tested,
Ms-PatA is the sole acetyltransferase that acetylates Ms-Acs.
The Western blots also revealed another acetylated protein
running at a slightly lower molecular mass (approx.
65 kDa) than Ms-Acs (Fig. 6a, marked by the arrowhead).
This additional acetylated protein was not observed in all
Strain



















































































































































































































































Fig. 6. Mycobacterial SrtN and PatA affect Ms-Acs acetylation. (a) Western blot of whole-cell lysates of indicated strains
harbouring empty vectors (EV) or complementing plasmids (genes as indicated). Molecular mass marker band sizes are
indicated on the left. The blot was probed with anti-acetyl-lysine antibody in the presence of BSA and shows all proteins
detected by the antibody. The arrow points to the specific band corresponding to Ms-Acs, the plus sign indicates a non-specific
band and the arrowhead indicates a specifically acetylated unknown protein. (b) Blot probed with anti-acetyl-lysine antibody in
the presence of acetylated BSA. (c) Quantification of acetylated Ms-Acs in the strains from (a), performed in triplicate. Each
sample was standardized by comparing to the amount of SigA (data not shown). Triplicate samples were then averaged and
normalized to the levels of acetylated Ms-Acs in the wild-type strain.
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strains, but it was specifically detected in the deacetylase
mutants (Dms-srtN and DdeAc) and in strains expressing
ms-patA from a plasmid. Thus, this band appeared to
correspond to another protein that can be acetylated by
Ms-PatA and deacetylated by Ms-SrtN.
Acetylated Ms-Acs and Ms5404 peptides are
detected in M. smegmatis whole-cell lysates
To help identify the acetylated proteins revealed by
Western blot, we employed quantitative MS. Whole cell
lysates from the wild-type and DdeAc strains (two
biological replicates of each) were separated by SDS-
PAGE and gel slices spanning proteins approximately 60–
75 kDa were excised, subjected to trypsin digestion and
analysed by LC-MS-MS. Peptide sequences were identified
using Andromeda (MaxQuant) and quantification was
performed using label-free quantification to measure the
AUC of the XIC of peptides (Cox et al., 2011). The analysis
unambiguously identified an acetylated Ms-Acs peptide,
which was acetylated at lysine residue 589 in the peptide
SGK(Ac)IMR (Fig. S2 available with the online version of
this paper). This acetylated lysine in Ms-Acs corresponds to
the site of acetylation in the S. enterica and B. subtilis Acs
proteins. The acetylated Acs peptide was, as expected, more
abundant (97.5-fold higher) in the DdeAc mutant com-
pared to the wild-type strain (Table 3). In contrast,
relatively equal levels of the Ms-Acs protein, quantified
with at least five unique peptides, were identified in the
DdeAc mutant and wild-type strains.
The 67kD Ms5404 protein was also identified as an
acetylated protein by the MS analysis. Ms5404 is a
predicted propionyl-CoA synthetase and the site of
acetylation was unambiguously localized at lysine-586 in
the identified peptide SGK(Ac)ILR (Fig S2). Notably, a
propionyl-CoA synthetase from S. enterica, PrpE, is
acetylated at the corresponding lysine (Garrity et al.,
2007). Interestingly, the acetylated Ms5404 peptide was
only detected in the DdeAc samples while the relative levels
of Ms5404 protein, quantified with at least five unique
peptides, were similar in the DdeAc mutant and wild-type
samples (Table 3). These results indicated that Ms5404 is
another lysine acetylated protein of M. smegmatis. Its size
of 67 kDa and our identification of acetylated peptides
only in the DdeAc samples makes it a leading candidate for
being the acetylated protein observed by Western blot in
the DdeAc mutant, but not in wild-type (Fig. 6a).
Ms-Acs, Ms-SrtN and Ms-PatA also regulate
propionate metabolism
Our finding that another acetylated protein of M.
smegmatis is Ms5404, a putative propionyl-CoA synthetase,
along with the fact that propionate can be a substrate for
Mt-Acs in vitro (Li et al., 2011a), suggested that propionate
metabolism in M. smegmatis may also be regulated by
lysine acetylation. Therefore, we went on to evaluate the
deacetylase and acetyltransferase mutants in media with
propionate as the sole carbon source. The Dms-srtN and
DdeAc mutants had reduced metabolic activity when
propionate was the sole carbon source (Fig. 7). Similar to
what was seen with acetate, addition of the Dms-patA
mutation into the DdeAc background rescued propionate
metabolism. All the propionate phenotypes were comple-
mented when the appropriate genes were provided on a
plasmid. These results indicated that Ms-SrtN and Ms-
PatA additionally regulate propionate metabolism in M.
smegmatis. While the Dms-acs mutant also had a
phenotype, the metabolism defect of the mutant in
propionate was not as complete as seen in acetate (compare
Fig. 3 and Fig. 7), suggesting there could be another protein
acting as a propionyl-CoA synthetase in the cell, with
Ms5404 being a leading candidate.
DISCUSSION
In comparison to eukaryotic cells, lysine acetylation in
bacteria is a more recently recognized phenomenon that
has so far only been studied in a small number of bacterial
species. Acs is the best-studied example of a bacterial
protein regulated by lysine acetylation, and previous in
vitro studies demonstrate the ability of mycobacterial Pat
and SrtN enzymes to acetylate and deacetylate purified Acs,
respectively (Gu et al., 2009; Li et al., 2011a; Xu et al.,
2011). Published work also shows that the Pat protein of
Mycobacterium bovis BCG is necessary for growth on
Table 3. Label-free quantification values obtained for Ms-Acs and Ms5404 proteins and their detectable acetylated peptides
Label-free AUC Mean fold change (DdeAc/wt)
wt-1 wt-2 DdeAc-1 DdeAc-2
Ms-Acs protein 2.26108 1.16108 6.46108 5.16107 2.1
Ms-Acs SGK(Ac)IMR 1.36107 ND 5.56108 7.56108 97.5
Ms5404 protein 5.66106 2.16106 3.66106 5.06106 1.1
Ms5404 SGK(Ac)ILR ND ND 1.16105 2.06106 1030.7
ND, peptides that had no detectable XIC-AUC in label-free quantification, but were assigned a value equal to a base line noise level of 1.06103 in
order to calculate a fold-change value.
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propionate as a sole carbon source (Nambi et al., 2013).
However, none of the past studies demonstrated the
biological significance of the Acs acetylation/deacetylation
regulatory circuit on acetate metabolism in mycobacteria.
In the present study, we demonstrated a role for the lysine
acetyltransferase Ms-PatA and deacetylase Ms-SrtN in
regulating Ms-Acs and acetate metabolism in the context
of the cell. Thus, the results reported here are significant in
providing critical validation of the data obtained by in vitro
studies with purified proteins. We also confirmed that the
cAMP binding of Ms-PatA is important for its function
and we identified an additional example of an acetylated
protein, Ms5404, in M. smegmatis.
Specificity of Ms-SrtN and Ms-PatA enzymes
There are several putative lysine acetyltransferases and
deacetylases encoded by the M. smegmatis genome. It was a
strong possibility that acetylation in mycobacteria would
involve multiple modifying enzymes and prove more
complicated than observed in vitro. In fact, in B. subtilis,
two deacetylases are required for Acs deacetylation and
growth on acetate (Gardner & Escalante-Semerena, 2009).
However, we found only one deacetylase, Ms-SrtN, acted
on acetylated Ms-Acs. Ms-SrtN is the orthologue of the
sole predicted deacetylase in M. tuberculosis, Mt-SrtN.
When complementing the Dms-srtN mutant phenotype we
used a plasmid expressing Mt-SrtN, which demonstrated
conservation of function of the M. tuberculosis and M.
smegmatis SrtN proteins. The functions of the other two
putative M. smegmatis deacetylases are still in question.
While there was no evidence for either Ms4620 or Ms0171
acting on Ms-Acs, they may deacetylate other substrates.
Given the large number of putative GNAT-type acetyl-
transferases (UniProt Consortium, 2012), we also thought
it possible that more than one of these proteins would act
on Ms-Acs, but that was not the case. Thus, there appears
to be a high level of substrate specificity for the Ms-SrtN
and Ms-PatA pair.
Data in this study are believed to be the first to show an
acetate phenotype for mycobacterial deacetylase mutants.
The acetate phenotypes of the deacetylase mutants (Dms-
srtN or DdeAc) were reproducible, complementable and
statistically significant, but they were not as severe as the
phenotype of the Dms-acs mutant. In fact, until we turned
to the resazurin assay to measure acetate metabolism it was
difficult to observe a phenotype, which may be why there
were no earlier reports of deacetylation regulating acetate
metabolism in intact cells. The more moderate phenotype
of the deacetylase mutants suggested that there still existed
some active unacetylated Ms-Acs in these strains. This
could be due to the presence of an unidentified deacetylase.
However, we think it more likely that the DdeAc acetate
phenotype is due to newly synthesized Ms-Acs that had yet
to be acetylated in the cell, possibly as a consequence of
limited amount or acetylation efficiency of Ms-PatA.
Support for this idea comes from experiments where the
acetate defect of the DdeAc mutant was enhanced by
providing an exogenous copy of Ms-PatA on a single copy
vector (Fig. 4, compare DdeAc and DdeAc Dms-patA+ms-
patA). In addition, overexpressing Ms-PatA from a multi-
copy vector in a wild-type background prevented M.
smegmatis growth on acetate (data not shown). These
experiments suggested that the level of Ms-PatA influences




































Fig. 7. Propionate metabolism is regulated by Ms-Acs, Ms-SrtN and Ms-PatA in M. smegmatis. Resazurin reduction of cells
growing with propionate as the sole carbon source was fluorescently monitored and quantified as in Fig. 2(f). The strains
included were wild-type (mc2155, pMV261), Dms-acs (JDH032, pMV261), Dms-acs complemented with ms-acs (JDH032,
pJH33), Dms-srtN (JDH008, pMV261), Dms-srtN complemented with mt-srtN (JDH008, pEP104), DdeAc (JDH043, pMV261),
DdeAc complemented with mt-srtN (JDH043, pEP104), DdeAc Dms-patA (JDH051, pMV261), DdeAc Dms-patA
complemented with ms-patA (JDH051, pJH40), Dms-patA (JDH050, pMV261), and Dms-patA complemented with ms-patA
(JDH050, pJH40). *P ,0.01 when compared to wild-type fluorescence in the same media.
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An additional metabolic process regulated by
Ms-Acs, Ms-SrtN and Ms-PatA
Our data also revealed a role for Ms-Acs, Ms-SrtN and Ms-
PatA in regulating propionate metabolism in M. smegmatis
(Fig. 7). In vitro studies show Mt-Acs to be able to use
propionate, in addition to acetate, to generate CoA
derivatives (Li et al., 2011a; Xu et al., 2011). However, it
is likely that Ms-Acs is not the sole propionyl-CoA
synthetase in M. smegmatis because the Dms-acs phenotype
in propionate was not complete. The other protein we
identified by MS as being lysine acetylated, Ms5404, is the
leading candidate for being an additional propionyl-CoA
synthetase that could enable propionate utilization by M.
smegmatis. In S. enterica, both Acs and a protein called
PrpE have propionyl-CoA synthetase activity but, in this
case, both proteins need to be absent in order to observe a
phenotype on propionate (Horswill & Escalante-Semerena,
1999).
In our study the Dms-patA mutation in a wild-type
background did not exhibit a defect in propionate
metabolism, although it did rescue the DdeAc phenotype.
This differs from the recent report of an M. bovis BCG Dpat
mutant (DKATbcg) being defective for growth in propion-
ate (Nambi et al., 2013). The BCG Dpat mutant phenotype
was interpreted as resulting from a build-up of Acs-
generated toxic propionyl-CoA metabolites. Interestingly,
in this study, it was also shown that the BCG Acs can be
propionylated by PatA and depropionylated by SrtN in
vitro (Nambi et al., 2013), suggesting that acetylation and
propionylation may provide overlapping levels of regu-
lation in mycobacteria. Because propionyl-CoA metabolite
accumulation can also be toxic to M. smegmatis (Upton &
McKinney, 2007), the different results we obtained with the
Dms-patA mutant may be accounted for by differences in
experimental conditions and/or the specific metabolic
pathways operating in each species to prevent propionyl-
CoA build-up (Rhee et al., 2011). It also remains possible
that the phenotype of the BCG DpatA mutant reflects PatA
regulated proteins other than Acs since the phenotype of a
BCG Dacs mutant in propionate is unknown. Nonetheless,
from the studies of DpatA mutants in M. smegmatis and
BCG it is evident that propionate metabolism in myco-
bacteria is regulated by PatA.
Expanding our understanding of mycobacterial
metabolic regulation
Until recently, the only mode of metabolic regulation
reported in mycobacteria was transcriptional regulation of
metabolic genes (Datta et al., 2011; Schnappinger et al.,
2003; Timm et al., 2003). Interestingly, both the myco-
bacterial SrtN and PatA enzymes themselves are regulated
by different cellular signals. Transcript levels of the patA
gene of M. bovis BCG are reported to be regulated by
propionate and SDS (Nambi et al., 2013). In addition,
cAMP binding to Mt-PatA causes major conformational
changes (Lee et al., 2012) and increases the acetylation
activity of both Ms-PatA and Mt-PatA proteins in vitro
(Nambi et al., 2010; Xu et al., 2011). Our data extend these
in vitro results in showing that cAMP binding is also
necessary for PatA activity in M. smegmatis cells. In M.
tuberculosis, cAMP levels are regulated by several condi-
tions associated with infection (Bai et al., 2011).
Interestingly, cAMP also regulates the PatZ lysine acetyl-
transferase of E. coli, but it does so by a different
mechanism involving transcriptional regulation (Castaño-
Cerezo et al., 2011).
On the deacetylase side of the equation, the mycobacterial
sirtuin deacetylases Ms-SrtN and Mt-SrtN are shown to be
NAD+-dependent deacetylases in vitro (Gu et al., 2009;
Nambi et al., 2013; Xu et al., 2011). NAD+ levels reflect the
energy status of the cell. In addition to cAMP and NAD+,
the level of acetyl-CoA, which is used in the acetylation
reaction and is another reflection of the carbon and energy
status of the cell, will also influence the amount of
acetylation that occurs. Consequently, reversible acetyla-
tion by the mycobacterial PatA and SrtN pair provides an
interesting example of how multiple signals and regulatory
networks can be integrated to achieve metabolic regulation.
There are likely to be many mycobacterial proteins regulated
by lysine acetylation besides Ms-Acs and Ms5404. In other
studies, a universal stress protein, Ms4207, of M. smegmatis
was reported to be acetylated by Ms-PatA (Nambi et al.,
2010) and FadD13 was identified as acetylated in M. bovis
BCG cells (Nambi et al., 2013). However, the biological
significance of Ms4207 or FadD13 acetylation has yet to be
shown. There are also multiple FadD proteins (fatty acyl-
CoA ligases) from M. tuberculosis shown to be acetylated and
deacetylated by PatA and SrtN with purified proteins in vitro
(Nambi et al., 2013). There is additionally a report of a Dms-
srtN mutant having a defect in DNA double strand break
repair, although this phenotype has not been linked to
deacetylation of any substrates (Li et al., 2011b). In the
future it will be important to identify the full acetylome of
mycobacterium species, especially M. tuberculosis.
Reversible acetylation is a strong candidate for dynamically
controlling metabolic pathways and enabling M. tuber-
culosis to quickly adapt to the changing host environment.
By showing here that the regulatory circuit of Acs
acetylation and deacetylation by PatA and SrtN enzymes
holds true in M. smegmatis, this work opens the door to
studying reversible acetylation and how it integrates
regulatory signals in the cellular environment of myco-
bacteria.
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